Nonoperating Income (Expense) in USD of ANAVEX LIFE SCIENCES CORP. from Q1 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Anavex Life Sciences Corp. quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2013 to Q3 2025.
  • Anavex Life Sciences Corp. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $1.02M, a 61.7% decline year-over-year.
  • Anavex Life Sciences Corp. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $5.03M, a 49.1% decline year-over-year.
  • Anavex Life Sciences Corp. annual Nonoperating Income (Expense) for 2025 was $5.03M, a 49.1% decline from 2024.
  • Anavex Life Sciences Corp. annual Nonoperating Income (Expense) for 2024 was $9.88M, a 19.6% increase from 2023.
  • Anavex Life Sciences Corp. annual Nonoperating Income (Expense) for 2023 was $8.26M, a 145% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

ANAVEX LIFE SCIENCES CORP. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $5.03M $1.02M -$1.64M -61.7% 01 Jul 2025 30 Sep 2025 10-K 25 Nov 2025
Q2 2025 $6.67M $1.22M -$1.17M -49.1% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $7.84M $1.32M -$761K -36.6% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $8.6M $1.48M -$1.28M -46.3% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2025
Q3 2024 $9.88M $2.65M +$211K +8.64% 01 Jul 2024 30 Sep 2024 10-K 25 Nov 2025
Q2 2024 $9.66M $2.39M +$97K +4.23% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 $9.57M $2.08M +$945K +83.4% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 $8.62M $2.76M +$364K +15.2% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025
Q3 2023 $8.26M $2.44M +$1.24M +103% 01 Jul 2023 30 Sep 2023 10-K 25 Nov 2025
Q2 2023 $7.02M $2.29M +$2.11M +1175% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $4.91M $1.13M +$21.3K +1.91% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $4.89M $2.39M +$1.52M +175% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024
Q3 2022 $3.37M $1.2M +$527K +77.8% 01 Jul 2022 30 Sep 2022 10-K 27 Nov 2023
Q2 2022 $2.84M $180K -$1.08M -85.7% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $3.92M $1.11M +$285K +34.5% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $3.63M $871K -$729K -45.6% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 $4.36M $677K -$875K -56.4% 01 Jul 2021 30 Sep 2021 10-K 27 Nov 2023
Q2 2021 $5.24M $1.26M -$367K -22.6% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $5.6M $826K +$290K +54% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $5.31M $1.6M +$482K +43.1% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 $4.83M $1.55M +$805K +108% 01 Jul 2020 30 Sep 2020 10-K 28 Nov 2022
Q2 2020 $4.03M $1.62M +$980K +152% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $3.04M $536K -$405K -43% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $3.45M $1.12M +$555K +98.8% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021
Q3 2019 $2.89M $746K +$414K +125% 01 Jul 2019 30 Sep 2019 10-K 28 Dec 2020
Q2 2019 $2.48M $645K -$1.12M -63.6% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $3.6M $941K +$931K +9029% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $2.67M $563K +$520K +1228% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020
Q3 2018 $2.15M $332K +$280K +539% 01 Jul 2018 30 Sep 2018 10-K 16 Dec 2019
Q2 2018 $1.87M $1.77M +$1.66M +1583% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 $210K $10.3K -$2.06M -99.5% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $2.27M $42.4K -$10.7K -20.1% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019
Q3 2017 $2.28M $52K -$25.8K -33.1% 01 Jul 2017 30 Sep 2017 10-K 25 Jan 2019
Q2 2017 $2.31M $105K +$45.8K +77.2% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $2.26M $2.07M +$1.92M +1285% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 $339K $53K -$543K -91.1% 01 Oct 2016 31 Dec 2016 10-Q 07 Feb 2018
Q3 2016 $882K $77.7K +$1.47M 01 Jul 2016 30 Sep 2016 10-K 25 Jan 2019
Q2 2016 -$585K $59.3K +$2.79M 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 -$3.37M $149K +$1.02M 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 -$4.39M $596K +$612K 01 Oct 2015 31 Dec 2015 10-Q 07 Feb 2017
Q3 2015 -$5M -$1.39M +$7.67M +84.7% 01 Jul 2015 30 Sep 2015 10-K 11 Dec 2017
Q2 2015 -$12.7M -$2.73M -$2.72M -26489% 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016
Q1 2015 -$9.95M -$867K -$869K 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016
Q4 2014 -$9.08M -$16K -$684K -102% 01 Oct 2014 31 Dec 2014 10-Q 08 Feb 2016
Q3 2014 -$8.4M -$9.06M 01 Jul 2014 30 Sep 2014 10-K 14 Dec 2016
Q2 2014 -$10.3K +$15.7K +60.5% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 $2.31K* -$18.7K 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q4 2013 $668K 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q2 2013 -$25.9K 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014
Q1 2013 $21K 01 Jan 2013 31 Mar 2013 10-Q/A 30 May 2014

ANAVEX LIFE SCIENCES CORP. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $5.03M -$4.84M -49.1% 01 Oct 2024 30 Sep 2025 10-K 25 Nov 2025
2024 $9.88M +$1.62M +19.6% 01 Oct 2023 30 Sep 2024 10-K 25 Nov 2025
2023 $8.26M +$4.89M +145% 01 Oct 2022 30 Sep 2023 10-K 25 Nov 2025
2022 $3.37M -$995K -22.8% 01 Oct 2021 30 Sep 2022 10-K 27 Nov 2023
2021 $4.36M -$469K -9.72% 01 Oct 2020 30 Sep 2021 10-K 27 Nov 2023
2020 $4.83M +$1.94M +66.9% 01 Oct 2019 30 Sep 2020 10-K 28 Nov 2022
2019 $2.89M +$741K +34.4% 01 Oct 2018 30 Sep 2019 10-K 28 Dec 2020
2018 $2.15M -$126K -5.53% 01 Oct 2017 30 Sep 2018 10-K 16 Dec 2019
2017 $2.28M +$1.4M +158% 01 Oct 2016 30 Sep 2017 10-K 25 Jan 2019
2016 $882K +$5.88M 01 Oct 2015 30 Sep 2016 10-K 25 Jan 2019
2015 -$5M +$3.4M +40.5% 01 Oct 2014 30 Sep 2015 10-K 11 Dec 2017
2014 -$8.4M -$6.84M -437% 01 Oct 2013 30 Sep 2014 10-K 14 Dec 2016
2013 -$1.56M 01 Oct 2012 30 Sep 2013 10-K 29 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.